Vicarious Surgical Inc. (RBOTW) — SEC Filings
Vicarious Surgical Inc. (RBOTW) — 33 SEC filings. Latest: 8-K (Dec 16, 2025). Includes 21 8-K, 6 10-Q, 2 DEF 14A.
View Vicarious Surgical Inc. on SEC EDGAR
Overview
Vicarious Surgical Inc. (RBOTW) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 3, 2025: Vicarious Surgical Inc. filed an 8-K on December 3, 2025, reporting events as of December 1, 2025. The filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. It also includes Regulation FD disclosures and f
Sentiment Summary
Across 33 filings, the sentiment breakdown is: 3 bearish, 30 neutral. The dominant filing sentiment for Vicarious Surgical Inc. is neutral.
Filing Type Overview
Vicarious Surgical Inc. (RBOTW) has filed 21 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 1 10-Q/A, 1 SC 13G/A with the SEC between Jan 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (33)
Risk Profile
Risk Assessment: Of RBOTW's 29 recent filings, 3 were flagged as high-risk, 11 as medium-risk, and 15 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $0 |
| Net Income | -$13.215M |
| EPS | -$2.23 |
| Debt-to-Equity | 0.77 |
| Cash Position | $23.963M |
| Operating Margin | N/A |
| Total Assets | $40.890M |
| Total Debt | $17.827M |
Key Executives
- John P. Morgan
Industry Context
Vicarious Surgical operates in the highly competitive and capital-intensive medical device industry, specifically focusing on robotic surgery. The market is characterized by significant R&D investment, long product development cycles, and stringent regulatory approvals. Key trends include increasing adoption of minimally invasive techniques and advancements in AI and robotics to enhance surgical precision and outcomes.
Top Tags
corporate-governance (7) · filing (5) · 10-Q (5) · management-change (4) · financials (4) · officer-changes (3) · corporate-filing (3) · compensation (3) · Vicarious Surgical (3) · SEC Filing (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Warrant Exercise Price | 11.50 | Price at which warrants can be exercised to purchase shares. |
| Par Value | 0.0001 | Class Common Stock Par Value Per Share |
| Exercise Price | 11.50 | Warrants to Purchase One Share of Class Common Stock |
| Net Loss (Q2 2025) | $13.215M | Improved from $15.205M in Q2 2024, but still significant. |
| Net Loss (YTD June 2025) | $28.609M | Reduced from $32.206M in YTD June 2024, indicating continued operational losses. |
| Cash & Short-term Investments | $23.963M | Deemed insufficient for next 12 months, raising going concern doubt. |
| Accumulated Deficit | $224.544M | Increased from $195.935M at Dec 31, 2024, reflecting ongoing losses. |
| Total Assets | $40.890M | Decreased from $67.719M at Dec 31, 2024, primarily due to cash burn. |
| Research and Development (Q2 2025) | $9.050M | Decreased from $10.924M in Q2 2024, indicating cost-cutting or project slowdown. |
| Revenue | 0 | Company has not generated any revenue since inception. |
| Annual Meeting Date | 20250627 | Shareholders will vote on proposals at this date. |
| Filing Date | 20250429 | Date the definitive proxy statement was filed. |
| SEC File Number | 001-39384 | Identifies the company's filings with the SEC |
| Central Index Key | 0001812173 | Unique identifier for the company in SEC filings |
| Commission File Number | 001-39384 | Vicarious Surgical Inc. |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Vicarious Surgical Inc. (RBOTW)?
Vicarious Surgical Inc. has 33 recent SEC filings from Jan 2024 to Dec 2025, including 21 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of RBOTW filings?
Across 33 filings, the sentiment breakdown is: 3 bearish, 30 neutral. The dominant sentiment is neutral.
Where can I find Vicarious Surgical Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Vicarious Surgical Inc. (RBOTW) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Vicarious Surgical Inc.?
Key financial highlights from Vicarious Surgical Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for RBOTW?
The investment thesis for RBOTW includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Vicarious Surgical Inc.?
Key executives identified across Vicarious Surgical Inc.'s filings include John P. Morgan.
What are the main risk factors for Vicarious Surgical Inc. stock?
Of RBOTW's 29 assessed filings, 3 were flagged high-risk, 11 medium-risk, and 15 low-risk.
What are recent predictions and forward guidance from Vicarious Surgical Inc.?
Forward guidance and predictions for Vicarious Surgical Inc. are extracted from SEC filings as they are enriched.